Elon Musk has said he plans to increase the production of Neuralink chips in 2026 and to automate the procedure of implanting them into humans. Neuralink “will start high-volume production of brain-computer interface devices” this year, said Musk in a post on X.
Neuralink, which was founded by Musk in 2016, is developing technology that enables people to control computers using an implanted microchip. While the company mentioned its initial purpose is to be helping patients with severe neurological conditions like Parkinson’s and Alzheimer’s to communicate and regain independence, Musk also raised the possibility of it being used to meld human consciousness with artificial intelligence.
READ: Elon Musk’s Neuralink raises $650 million in Series E funding (
Musk also said in Thursday’s X post that the medical process to implant the chips will “move to a streamlined, almost entirely automated surgical procedure in 2026.” Device threads will go through the dura — the tough outer membrane that protects the brain and spinal cord — without the need to remove it, Musk said. He added that this is “a big deal.”
The Neuralink chip is the size of a coin. An array of thin threads, each roughly 20 times thinner than a human hair, fan out into the patient’s brain from the chip. Inserting the device has previously required a human surgeon to remove a portion of the individual’s skull, before a robotic arm takes over to insert the chip.
READ: Neuralink eyes $1 billion in revenue by 2031: Report (
The company began human trials of its brain implant in 2024 after addressing safety concerns raised by the U.S. Food and Drug Administration, which had initially rejected its application in 2022. Neuralink said in September that 12 people worldwide with severe paralysis have received its brain implants and were using them to control digital and physical tools through thought.
It also raised $650 million in a Series E funding round, with ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Equity Partners, and Vy Capital as investors. The company said the funding would bring the technology to more people, “restoring independence for those with unmet medical needs and pushing the boundaries of what’s possible with brain interfaces.”
Musk previously suggested that Neuralink could have over a thousand patients with the implant by 2026. In November 2024, the company went on a hiring spree, searching for manufacturing technicians and microfabrication specialists as it looked to ramp up production.
1 Comment
I stopped most of my Parkinson’s disease medications due to severe side effects and I started on herbal treatments from Limitless Herbs Centre the treatment has made a very huge difference for me. My symptoms including body weakness and Swallowing difficulties disappeared after few months on the treatment. I am getting active again since starting this treatment.